Xenon Pharmaceuticals (XENE) Tops Q1 EPS by 6c

Xenon Pharmaceuticals (NASDAQ: XENE) reported Q1 EPS of ($0.35), $0.06 better than the analyst estimate of ($0.41). Revenue for the quarter came in at $8.8 million versus the consensus estimate of $8.7 million.

For earnings history and earnings-related data on Xenon Pharmaceuticals (XENE) click here.

You May Also Be Interested In

• Barclays sees global expansion intact, warns against market complacency
• Darden Restaurants posts fiscal 2026 results, raises dividend, OKs buyback
• Acuity Brands (AYI) Tops Q3 EPS by 15c